“New discovery in Israel manages to cure fibromyalgia.”
“Great news comes from Israel about a new treatment for fibromyalgia (pain syndrome) also reduces or completely eliminates the need for medication. Fibromyalgia is almost impossible to diagnose. This chronic pain syndrome is characteristic mainly affects women.
The disease is often caused by head trauma, a neurological infection, or severe emotional stress. It is characterized by symptoms such as musculoskeletal pain, fatigue, memory loss and mood swings.
Fibromyalgia is often confused with other diseases and most patients suffer months, even years, from relentless pain before being properly diagnosed. Once diagnosed, patients enjoy a little rest as few therapies have been effective in appeasing their symptoms.
A new study published in PLoS ONE by researchers at Tel Aviv University may change course.
The research found that women with fibromyalgia were able to dramatically reduce or even eliminate the use of medication for pain after treatment with hyperbaric oxygen.
The study was led by the late Professor Eshel Ben-Jacob, UTA School of Physics and Astronomy and Dr. Shai Efrati School of Neuroscience UTA and Assaf Harofeh Medical Center, along with Professor Dan Buskila’s Soroka Medical Center, and was led by a team Of UTA scientists, Rice University, Assaf Harofeh Medical Center, Ben-Gurion University and Tel Aviv Sourasky Medical Center.
The researchers believe they also identified the main factor that causes fibromyalgia: a change in the brain’s mechanism for pain processing.
“As a physician, for me the most important finding is that 70 percent of patients could recover from their fibromyalgia symptoms,” Efrati said. “The most exciting thing for the world of research results, however, is that we were able to map the brain regions that perform poorly and are responsible for the syndrome.”
Hyperbaric oxygen chambers expose patients to pure at higher pressures than normal oxygen and are commonly used to treat patients with stroke, burns, carbon monoxide poisoning, and decompression sickness.
The clinical trial, which exposes participants to two months of hyperbaric oxygen therapy, found significant changes in brain activity and symptoms of 70 percent of participants.
The study included 60 women who had been diagnosed with fibromyalgia at least two years earlier. Half of the 48 patients who completed treatment received 40 treatments of hyperbaric oxygen therapy 90 minutes exposing patients to pure oxygen at twice atmospheric pressure five days a week over two months.
The success of the treatment allowed patients to reduce or eliminate the use of pain medication dramatically. “Medication intake relieves pain, but does not reverse the condition. But treatments with hyperbaric oxygen could reverse the condition, “said Efrati, adding that the results warrant further study, he said.
“The results are of great importance, hyperbaric oxygen therapy treatments are designed to meet the true cause of fibromyalgia is the pathology of the brain responsible for the syndrome. This means that repairing the brain, including neuronal regeneration, is possible, even for chronic diseases, and pain syndromes should be considered for all future developmental treatments. ”
The researchers did find some discrepancies between different patients with fibromyalgia. When fibromyalgia was triggered by a traumatic brain injury, for example, they witnessed a complete resolution without further treatment.
But when the trigger has been attributed to other causes, such as illnesses related to fever, patients need regular maintenance therapy.
Researchers continue to study now performing comprehensive studies on brain tissue renewal under hyperbaric conditions.
What do our doctors and well-informed readers think? Could this therapy help to find a treatment for patients with Alzheimer’s disease? “